Merontos, Menzl Mae V.

HRN: 13 21 16  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2023
CEFUROXIME 500MG (TAB)
05/28/2023
06/03/2023
PI
500mg
BID
Uti
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: